Narrow your search
An experimental type of vaccine that aims to treat, as opposed to prevent, metastatic breast and ovarian cancer shows promise in a small clinical trial.
U.K. researchers announce approval to launch the first human clinical trial of a genetically modified anti-HIV microbicide called P2G12, grown in Germany.
More than a decade of work in Canada and Sweden leads to the successful implants of artificial corneas in 10 Swedish patients with advanced keratoconus, or central corneal scarring.
A member of Stanford's technology licensing office recounts a mid-1990s visit from Larry Page.